Jennison Associates
TMCI icon

Jennison Associates’s Treace Medical Concepts TMCI Stock Holding History

Jennison Associates’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-560,652
Closed -$17.5M – 726
2021
Q2 		$17.5M Buy
+560,652
New +$17.8M 0.01% 389

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Jennison Associates's TMCI Position: Q3 2021 in Review

Jennison Associates sold out of Treace Medical Concepts (TMCI) in Q3 2021, closing a stake of 560,652 shares — an estimated $17.5M sold.

Jennison Associates first reported a position in TMCI in Q2 2021 and held it in 1 quarter. The position peaked at $17.5M in Q2 2021. 62 funds tracked by Wall St. Rank hold TMCI as of Q3 2021.

  • Jennison Associates reported no remaining Treace Medical Concepts position as of Q3 2021 after selling out during the quarter.
  • Jennison Associates sold 560,652 Treace Medical Concepts shares in Q3 2021, an estimated $17.5M.
  • Jennison Associates first reported a position in Treace Medical Concepts in Q2 2021 and held it in 1 quarter.
  • Jennison Associates's Treace Medical Concepts position peaked at $17.5M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2021.

Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.